Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 組換えタンパク質 > 免疫チェックポイントタンパク質

Human LAG-3 Recombinant Protein (C-His) (HB613011)

Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
Human LAG-3 Recombinant Protein (C-His)
価格(USD):
スペック:
  • 50ug
  • 100ug
  • 1mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HB613011
説明
Recombinant Human CD223/LAG3 Protein, C-His (HB613011) expressed in Mammalian Cells, spanning Met1-Leu450. Purity: >90% by SDS-PAGE.
Highlights
  • ●His-Tagged — N-terminal 6×His tag for IMAC purification.
  • ●Mammalian Expression — Proper folding and native glycosylation.
  • ●High Purity — >90% purity verified by SDS-PAGE.
発現システムMammalian cells
アクセッション番号P18627
タンパク質長Met1-Leu450
アプリケーションELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
種Homo sapiens (Human)
性質 Recombinant
ターゲット CD223, FDC, LAG-3, LAG3, Lymphocyte activation gene 3 protein, Secreted lymphocyte activation gene 3 protein, sLAG-3
エンドトキシンレベル Please contact with the lab for this information.
純度 >90% as determined by SDS-PAGE.
予測分子量 49.72 kDa
形態 Lyophilized
保存バッファー Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

再構成 Reconstitute in sterile water for a stock solution. Adjust the volume of sterile water so that, after reconstitution, the final stock concentration matches the value indicated on the product label or datasheet.

RECONSTITUTION PROTOCOL
1. Allow the product to be reconstituted and the reconstitution diluent to reach room temperature.
2. Tap or briefly centrifuge the product vial before opening to dislodge any lyophilized material that may be dispersed on the wall or cap of the vial.
3. Use the diluent and stock concentration recommended in the product datasheet. If preparing a stock concentration higher than recommended, contact Technical Service.
4. After adding the diluent, re-cap the vial and invert gently by hand or place on a slow rocking platform to allow the reconstitution diluent to coat all the surfaces inside the vial. Note: Do not mix by vortexing or by pipetting the material up and down.
5. Allow the vial to sit at room temperature with gentle agitation for at least 15 minutes before aliquotting or using.
6. Store the reconstituted material in single use aliquots in polypropylene or siliconized tubes. Aliquots of 10 μL or larger are recommended.
発送 In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
別名CD223, FDC, LAG-3, LAG3, Lymphocyte activation gene 3 protein, Secreted lymphocyte activation gene 3 protein, sLAG-3
背景

Lymphocyte activation gene 3 protein (CD223/LAG3) is a ~57 kDa protein. Inhibitory receptor on antigen activated T-cells. Delivers inhibitory signals upon binding to ligands, such as MHC class II, its main ligand present at the surface of antigen-presenting cells (APCs), and FGL1, which is secreted by hepatocytes and certain types of tumor cells. Ligand-binding initiates a signaling that inhibits the T-cell receptor (TCR) in the immunological synapse, preventing T-cell activation. Mechanistically, ligand-binding promotes (1) ubiquitination of the KIEELE motif, unleashing the RRFSALE motif from the membrane and (2) leading to the formation of condensates with the TCR component CD3E, thereby disrupting the association between CD3E and LCK and preventing TCR activation. May inhibit antigen-specific T-cell activation in synergy with PDCD1/PD-1. CD223 is the therapeutic target of relatlimab (Opdualag).

1. Camisaschi, C. et al. (2010) Journal of immunology (Baltimore, Md. : 1950) 184, 6545-51. PMID: 20421648
2. Ming, Q. et al. (2022) Nature immunology 23, 1031-1041. PMID: 35761082
3. Huard, B. et al. (1994) European journal of immunology 24, 3216-21. PMID: 7805750
4. Huard, B. et al. (1996) European journal of immunology 26, 1180-6. PMID: 8647185
5. Wang, J. et al. (2019) Cell 176, 334-347.e12. PMID: 30580966
6. MacLachlan, BJ. et al. (2021) European journal of immunology 51, 331-341. PMID: 32920841
7. Petersen, J. et al. (2024) Science immunology 9, eads5122. PMID: 39671469
8. Huard, B. et al. (1995) European journal of immunology 25, 2718-21. PMID: 7589152
10. Jiang, Y. et al. (2025) Cell 188, 2354-2371.e18. PMID: 40101708
注意事項 For research use only.
イメージ
  • Human LAG-3 Recombinant Protein (C-His)

    SDS-PAGE

    SDS-PAGE for Recombinant Human CD223/LAG3 Protein, C-His

  • Human LAG-3 Recombinant Protein (C-His)

    Bioactivity

    Detects Fianlimab in indirect ELISAs.

  • Human LAG-3 Recombinant Protein (C-His)

    Bioactivity

    Detected by Research Grade Anti-Human CD223/LAG3 (GSK2831781) (Catalog No: HB613166) in indirect ELISA

  • Human LAG-3 Recombinant Protein (C-His)

    Bioactivity

    Detected by Pavunalimab (Catalog No: HB613086) in indirect ELISA.

  • Human LAG-3 Recombinant Protein (C-His)

    Bioactivity

    Detected by Tuparstobart (Catalog No: HB613206) in indirect ELISA.

  • Human LAG-3 Recombinant Protein (C-His)

    Bioactivity

    Detected by Fanastomig (Catalog No: HB613246) in indirect ELISA.

  • Human LAG-3 Recombinant Protein (C-His)

    Bioactivity

    Detected by Negalstobart (Catalog No: HB613256) in indirect ELISA.

  • Human LAG-3 Recombinant Protein (C-His)

    Bioactivity

    Detected by Cugrastomig (Catalog No: HB613276) in indirect ELISA.

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト